Alnylam Pharmaceuticals, Inc 10-Q for FY2020 Q2
Alnylam Pharmaceuticals, Inc. (ALNY)
10-Q
2020-08-06
For: 2020-06-30
View Original
Added on
April 09, 2026
About this 10-Q
Alnylam Pharmaceuticals, Inc filed this 10-Q on August 6, 2020, covering the quarter ended June 30, 2020 (FY2020 Q2).
Headline figures
Quarter ended June 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $103.96M
- up 132.5% from $44.71M a year earlier
- Net loss
- $179.23M
- compared with a net loss of $219.48M a year earlier